President And Ceo
CurrentActuate Therapeutics, Inc. is a private biopharmaceutical company developing novel therapeutics that target Glycogen Synthase Kinase-3β (GSK-3β). Activity and overexpression of GSK-3β have been implicated in many conditions, including Alzheimer’s disease, bipolar disorder, diabetes mellitus type II, inflammatory conditions, and cancer. Our focus is on the development of compounds for combination use in high impact carcinomas including glioblastoma, ovarian, breast, and pancreatic cancers. In addition, we are advancing research for the development of our compounds for the treatment of inflammatory diseases leading to fibrosis, where early in vivo studies are yielding promising results.